Q1 2026 earnings call recap: guidance reaffirmed but pressured by U.S. pricing; GLP-1 partnerships grow and China recovery eyed.
Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results